Faculty profile

Peter Black

ResearcherPathology and Laboratory MedicineUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Peter Black

Researcher

Pathology and Laboratory Medicine

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
22 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 9 research grants (9 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

214

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Machine Learning Prostate Cancer Digital Pathology Bladder Cancer Multi-Parametric Imaging Ultrasound Imaging Bladder Preservation Comparative Effectiveness

Latest papers

Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer.
Experimental and molecular pathology · 2026
A bladder cancer-associated gene signature for exploratory qPCR-based survival stratification in NAC-Treated muscle-invasive bladder cancer.
Journal of translational medicine · 2026
Automated H-Scoring in Muscle-Invasive Bladder Cancer IHC: An Internal Validation Study.
Diagnostics (Basel, Switzerland) · 2026

All 67 publications

Latest funding

Stimulated Raman Histology for Real-Time Identification and Risk Stratification of Prostate Cancer
CIHR · 2025 · Co-investigator
$887,400
aRtificial intelligence-driven computational pathology platform for blAdder Cancer subTyping (REACT)
CIHR · 2024 · Principal investigator
$845,326
Copper Associated Immunogenic Cell Death: Improving the Therapeutic Potential of Immune Check Point Inhibitors for the Treatment of Metastatic Bladder Cancer
CIHR · 2024 · Co-investigator
$1,028,926

All 22 grants and awards

67 publications.

Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer.

Sakatani T, Tanaka S, Murakami K, Jinno C, Aguilar F, Bresee C, Chan OTM, Luthringer DJ, Contreras-Sanz A, Black P, Rosser CJ, Furuya H

Experimental and molecular pathology2026

DOI: 10.1016/j.yexmp.2026.105039 PMID: 41843975

A bladder cancer-associated gene signature for exploratory qPCR-based survival stratification in NAC-Treated muscle-invasive bladder cancer.

Chen X, Sakatani T, Tanaka S, Contreras-Sanz A, Black P, Rosser CJ, Furuya H

Journal of translational medicine2026

DOI: 10.1186/s12967-026-08681-2 PMID: 42482080

Automated H-Scoring in Muscle-Invasive Bladder Cancer IHC: An Internal Validation Study.

Yap M, Mihai IM, Alanazi MAA, Olteanu GE, Contreras-Sanz A, Black P, Wang G

Diagnostics (Basel, Switzerland)2026

DOI: 10.3390/diagnostics16111673 PMID: 42279541

Shift happens: a fairness-oriented framework for medical classification under hidden bias.

To MNN, Kim D, Harmanani M, Wilson PFR, Fooladgar F, Sojoudi S, Jamzad A, Abdalla S, Tsang T, Luong C, Chang S, Black P, Siemens R, Leveridge M, Krishnan RG, Mousavi P, Abolmaesumi P

International journal of computer assisted radiology and surgery2026

DOI: 10.1007/s11548-026-03624-0 PMID: 42032429

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Contieri R, Gontero P, Hurle R, Afferi L, Albisinni S, Babjuk M, Birtle A, Black P, Brausi M, Bruins M, Čapoun O, Carrion A, Catto J, Choudhury A, Cimadamore A, Comperat E, Daneshmand S, D'andrea D, Del Giudice F, Escrig JLD, Hensley P, Krajewski W, Laukhtina E, Li R, Liedberg F, Lotan Y, Marcq G, Mariappan P, Mari A, Martini A, Lecomte AM, Meijer R, Mir MC, Mori K, Moschini M, Mostafid H, O'Donnell M, Palou J, Panebianco V, Perdonà S, Porten S, Psutka S, Rink M, Roupret M, Seisen T, Soloway M, Soukup V, Steinberg G, Stenzl A, Teoh JY, Tully K, van der Heijden T, van Rhijn BWG, Witjes A, Xylinas E, Kamat AM, Pradere B, Mertens LS

Nature reviews. Urology2026

DOI: 10.1038/s41585-026-01137-8 PMID: 41922791

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker.

Pece A, Lovato G, Cela I, Mercatelli A, Ferro B, Nikkola J, Pagotto S, Grottola T, De Laurenzi V, Cicchetti R, Marchetti A, Schips L, Lattanzio R, Iacobelli S, Capone E, Black P, Daugaard M, Marchioni M, Sala G

Molecular oncology2026

DOI: 10.1002/1878-0261.70140 PMID: 41046347

Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer.

Dyrskjøt L, Black P, Lerner S, Theodorescu D

Bladder cancer (Amsterdam, Netherlands)2025

DOI: 10.1177/23523735251384859 PMID: 41140788

Reply by Authors.

Lotan Y, Daneshmand S, Shore N, Black P, Scarpato KR, Patel A, Lough T, Shoskes DA, Raman JD

The Journal of urology2024

DOI: 10.1097/ju.0000000000004028 PMID: 38728316

A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.

Lotan Y, Daneshmand S, Shore N, Black P, Scarpato KR, Patel A, Lough T, Shoskes DA, Raman JD

The Journal of urology2024

DOI: 10.1097/ju.0000000000003991 PMID: 38700731

LensePro: label noise-tolerant prototype-based network for improving cancer detection in prostate ultrasound with limited annotations.

To MNN, Fooladgar F, Wilson P, Harmanani M, Gilany M, Sojoudi S, Jamzad A, Chang S, Black P, Mousavi P, Abolmaesumi P

International journal of computer assisted radiology and surgery2024

DOI: 10.1007/s11548-024-03104-3 PMID: 38598142

Something wrong or missing on this profile? Suggest a correction

Peter Black

Research

Latest papers

Latest funding

Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer.

A bladder cancer-associated gene signature for exploratory qPCR-based survival stratification in NAC-Treated muscle-invasive bladder cancer.

Automated H-Scoring in Muscle-Invasive Bladder Cancer IHC: An Internal Validation Study.

Shift happens: a fairness-oriented framework for medical classification under hidden bias.

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker.

Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer.

Reply by Authors.

A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.

LensePro: label noise-tolerant prototype-based network for improving cancer detection in prostate ultrasound with limited annotations.

Next Generation Micro-ultrasound Technology for Detection and Monitoring of Prostate Cancer

Frequent collaborators

Wassim Kassouf

Purang Abolmaesumi

Alan So

Parvin Mousavi

Bobby Shayegan

Martin Gleave

Neil Fleshner

Gang Wang

Scott Tyldesley

Libni Eapen

Robert Siemens

Olli Saarela

Larry Goldenberg

Gad Abikhzer

Septimiu Salcudean

Girish Kulkarni

Ronald Moore

Ilias Cagiannos

Marie-Pier St-Laurent

Christina Luong

Alan Nichol

Stuart Peacock

Teresa Tsang

Dirk Lange

Mads Daugaard

Antonio Finelli

Srikala Sridhar

Edward Matsumoto

Jean-Claude Tardif

Jean-Claude Tardif

Katherine Zukotynski